In-Sik Shin

Title: In-Sik Shin: Innovator in Pharmaceutical Composition for Chronic Obstructive Lung Disease

Introduction

In-Sik Shin is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at preventing and treating chronic obstructive lung disease (COPD). His innovative work has the potential to impact the lives of many suffering from this condition.

Latest Patents

In-Sik Shin holds a patent for a pharmaceutical composition designed to prevent and treat chronic obstructive lung disease. This composition includes an extract, fraction, or active fraction obtained through organic solvent fractionation. The active ingredient effectively inhibits the expression of MUC5AC induced by TNF-α and reduces inflammatory responses in human lung cancer mucosal cells. The formulation has shown promise in reducing the number of inflammatory cells in bronchoalveolar lavage fluid in COPD mouse models, inhibiting reactive oxygen species production, and decreasing cytokine levels.

Career Highlights

Throughout his career, In-Sik Shin has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and Yungjin Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

In his professional journey, In-Sik Shin has collaborated with notable colleagues, including Sei-Ryang Oh and Kyung Seop Ahn. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

In-Sik Shin's innovative work in pharmaceutical compositions for chronic obstructive lung disease showcases his dedication to improving health outcomes. His contributions to the field are significant and reflect his commitment to advancing medical science.